| Primary |
| Herpes Zoster |
34.9% |
| Drug Use For Unknown Indication |
15.4% |
| Hypertension |
12.2% |
| Genital Herpes |
8.3% |
| Gastritis |
3.6% |
| Product Used For Unknown Indication |
3.5% |
| Constipation |
3.2% |
| Insomnia |
2.6% |
| Herpes Simplex |
2.2% |
| Herpes Virus Infection |
2.1% |
| Diabetes Mellitus |
2.1% |
| Angina Pectoris |
1.9% |
| Pain |
1.7% |
| Gastric Ulcer |
1.2% |
| Osteoporosis |
1.1% |
| Cerebral Infarction |
1.1% |
| Oral Herpes |
0.8% |
| Pruritus |
0.7% |
| Asthma |
0.7% |
| Immunosuppressant Drug Therapy |
0.7% |
|
| Drug Ineffective |
15.4% |
| Vomiting |
14.5% |
| Renal Failure Acute |
10.8% |
| Rash |
5.6% |
| Overdose |
4.3% |
| Herpes Virus Infection |
4.2% |
| Nausea |
4.0% |
| Renal Failure |
4.0% |
| Restlessness |
4.0% |
| Renal Impairment |
3.8% |
| Somnolence |
3.8% |
| Speech Disorder |
3.8% |
| Headache |
3.5% |
| Nervous System Disorder |
3.2% |
| Therapeutic Response Unexpected |
2.8% |
| Herpes Simplex |
2.7% |
| Renal Disorder |
2.6% |
| Urine Output Decreased |
2.4% |
| Urticaria |
2.3% |
| Tremor |
2.3% |
|
| Secondary |
| Herpes Zoster |
29.2% |
| Genital Herpes |
10.8% |
| Bipolar Disorder |
10.3% |
| Product Used For Unknown Indication |
7.9% |
| Post Herpetic Neuralgia |
6.9% |
| Drug Use For Unknown Indication |
6.1% |
| Prophylaxis |
4.7% |
| Hypertension |
4.1% |
| Insomnia |
2.7% |
| Pain |
2.2% |
| Hypomania |
2.2% |
| Constipation |
1.8% |
| Hiv Infection |
1.8% |
| Herpes Simplex |
1.5% |
| Asthma |
1.5% |
| Multiple Myeloma |
1.3% |
| Oral Herpes |
1.3% |
| Depression |
1.2% |
| Herpes Virus Infection |
1.2% |
| Acute Lymphocytic Leukaemia |
1.2% |
|
| Vomiting |
14.1% |
| Renal Failure |
12.2% |
| Renal Failure Acute |
10.2% |
| Drug Ineffective |
7.1% |
| Pyrexia |
7.1% |
| Renal Impairment |
7.1% |
| Speech Disorder |
5.5% |
| Restlessness |
5.1% |
| Overdose |
3.9% |
| Toxic Encephalopathy |
3.5% |
| Thrombocytopenia |
3.1% |
| Weight Increased |
3.1% |
| Urine Output Decreased |
2.7% |
| Urticaria |
2.7% |
| Somnolence |
2.4% |
| Vulvovaginal Mycotic Infection |
2.4% |
| Drug Interaction |
2.0% |
| Herpes Zoster |
2.0% |
| Jaundice |
2.0% |
| Malaise |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.6% |
| Drug Use For Unknown Indication |
17.5% |
| Multiple Myeloma |
10.0% |
| Prophylaxis |
8.4% |
| Pain |
4.5% |
| Hiv Infection |
4.1% |
| Depression |
3.7% |
| Hypertension |
3.6% |
| Acute Myeloid Leukaemia |
2.7% |
| Contraception |
2.6% |
| Rheumatoid Arthritis |
1.9% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Infection Prophylaxis |
1.7% |
| Herpes Zoster |
1.6% |
| Anxiety |
1.6% |
| Constipation |
1.6% |
| Herpes Virus Infection |
1.6% |
| Nausea |
1.5% |
| Crohn's Disease |
1.5% |
| Chronic Lymphocytic Leukaemia |
1.5% |
|
| Vomiting |
12.3% |
| Weight Decreased |
8.7% |
| White Blood Cell Count Decreased |
8.6% |
| Weight Increased |
8.0% |
| Pulmonary Embolism |
6.7% |
| Thrombocytopenia |
6.0% |
| Pneumonia |
5.2% |
| Pyrexia |
4.9% |
| Sepsis |
4.6% |
| Pain |
4.4% |
| Nausea |
4.1% |
| Rash |
3.9% |
| Urinary Tract Infection |
3.1% |
| Febrile Neutropenia |
3.1% |
| Deep Vein Thrombosis |
2.9% |
| Death |
2.8% |
| Herpes Zoster |
2.8% |
| Vision Blurred |
2.7% |
| Drug Ineffective |
2.6% |
| Diarrhoea |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
44.7% |
| Herpes Zoster |
26.3% |
| Epilepsy |
10.5% |
| Herpes Simplex |
5.3% |
| Product Used For Unknown Indication |
5.3% |
| Crohn's Disease |
2.6% |
| Hormone Therapy |
2.6% |
| Migraine Prophylaxis |
2.6% |
|
| Grand Mal Convulsion |
30.8% |
| Drug Interaction |
15.4% |
| Subdural Haematoma |
15.4% |
| Inhibitory Drug Interaction |
7.7% |
| Rash |
7.7% |
| Renal Failure Acute |
7.7% |
| Salpingo-oophoritis |
7.7% |
| Weight Decreased |
7.7% |
|
